📰 Chemo Research News
Chemo Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chemo Research. Real-time updates on events, politics, business and more.
April 5, 2024
SAINT LAURENT, Quebec, April 05, 2024 -- IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response...
November 10, 2023
Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
November 9, 2023
SAINT LAURENT, Quebec, Nov. 09, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the Company or IntelGenx) toda...
September 19, 2023
SAINT LAURENT, Quebec, Sept. 19, 2023 -- IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the...
May 21, 2023
BALTIMORE — Patients with heavy menstrual bleeding who received the levonorgestrel 52 mg intrauterine device experienced significant and rapid decreases in uterine bleeding after placement, a researcher reported here.Blood loss was reduced by more than 90% over 6 months after placement of the Liletta levonorgestrel-releasing intrauterine system (AbbVie/Medicines360) compared with baseline
May 11, 2023
SAINT LAURENT, Quebec, May 11, 2023 -- IntelGenx Technologies Corp. today reported financial results for the first quarter ended March 31, 2023. All dollar amounts are expressed in... | May 11, 2023
April 27, 2023
By Robb M. Stewart IntelGenx Corp.s shares jumped Thursday after the Canadian drug-delivery company and its partner received the U.S. Food and Drug Administrations review of the data... | April 27, 2023
April 27, 2023
By Robb M. Stewart IntelGenx Corp. said Thursday its partner will address concerns this quarter being raised by the U.S. Food and Drug Administration in a complete response letter to an... | April 27, 2023
April 13, 2023
SAINT LAURENT, Quebec, April 13, 2023 -- IntelGenx Technologies Corp. today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst... | April 13, 2023
April 13, 2023
To assess the effects that failure to take pills has on the efficacy of combined oral contraceptives, the researchers reviewed data from a pair of parallel phase 3 trials.